#JPM20: Vertex lays out post-CF ambitions as Gilead demurs on acquisition

#JPM20: Vertex lays out post-CF ambitions as Gilead demurs on acquisition

Submitted by admin on January 13, 2020 - 11:53pm
Source: 
Endpoints
News Tags: 
Vertex Pharmaceuticals
cystic fibrosis
JPMHC 2020
Gilead Sciences
M&A
Headline: 
#JPM20: Vertex lays out post-CF ambitions as Gilead demurs on acquisition
snippet: 

 Vertex laid out a vision for a post-CF and a post-Jeffrey Leiden future at their investor presentation Monday morning. It looks a lot like the past.

Do Not Allow Advertisers to Use My Personal information